JPMorgan Downgrades BioNTech (BNTX) to Underweight, 'Waiting for a More Catalyst-Rich Period'

December 1, 2023 1:51 AM EST Send to a Friend
(Updated - December 1, 2023 4:23 AM EST)

JPMorgan analyst Jessica Fye downgraded BioNTech (NASDAQ: BNTX) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login